PASG
Passage Bio, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website assagebio.com
- Employees(FY) 85
- ISIN US7027121000
Performance
-9.59%
1W
+6.45%
1M
+1.93%
3M
+119.27%
6M
+30.69%
YTD
+34.42%
1Y
Profile
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; and PBKR03, a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company also develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other program for huntington's disease. Passage Bio, Inc. has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. The company was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.
Technical Analysis of PASG 2024-05-10
Overview:
In analyzing the technical indicators for PASG over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive assessment of the stock's potential price movement. By examining key metrics such as moving averages, MACD, RSI, Bollinger Bands, and OBV, we aim to offer valuable ins...
Recent News & Updates
- 2024-05-16 00:00
- 2024-05-14 01:54
PASG Stock Earnings: Passage Bio Beats EPS for Q1 2024(Investorplace)
- 2024-05-13 19:00
- 2024-04-21 19:00
- 2024-03-06 23:00
- 2024-03-06 00:52
PASG Stock Earnings: Passage Bio Beats EPS for Q4 2023(Investorplace)
- 2024-03-04 18:00
- 2024-03-03 18:00
- 2024-02-26 18:00
Passage Bio to Participate in Upcoming Investor Conferences(Globenewswire)
- 2024-02-01 06:09
7 Analyst-Backed Stocks With Promising 10-Bagger Potential(Yahoo Finance)
- 2024-01-30 18:30
- 2023-12-25 09:14
7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight(Yahoo Finance)
- 2023-12-19 18:00
- 2023-11-17 03:30
- 2023-11-12 18:00
- 2023-10-29 19:00
- 2023-10-20 04:30
- 2023-09-24 19:00
- 2023-08-10 22:04
- 2023-08-06 19:15
- 2023-08-06 19:00
- 2023-07-31 19:00
Passage Bio to Participate in Upcoming Investor Conferences(Yahoo Finance)
- 2023-07-30 19:00
- 2023-07-24 00:37
Passage Bio reduces staff by 26% in latest round of job cuts(Yahoo Finance)
- 2023-07-05 23:17
12 Best Nano Cap Stocks To Buy Now(Yahoo Finance)
- 2023-06-04 19:00
- 2023-05-10 19:00
- 2023-05-03 19:00
- 2023-04-21 04:01
- 2023-04-16 19:00
Page 1 of 4
previousnext